CML 2 Flashcards

1
Q

what is CML

A

stem cell disease w excess myeloid cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

clin molecular lab questions

A

can disorder be defined? pose serious health prob? is there treatment? is there biomarker to assess? easy to measure? correlation to disease?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what % survive 5 years

A

67%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

visualize xsomes by karyotyping

A

culture in growth medium, incubate for 2-3 days, add microtubule inhibitor to stop mitosis in metaphase, move cells to tube & centrifuge to conc in layers, transfer to tube (w fixative), stain to enhance xsomes, ID/photograph xsomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

karyotyping for diagnosis pros

A

gold standard, can ID variants of translocatuon, quantify # cells w translocation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

kartyotyping cons

A

need viable dividing cells, expensive, labor intensive, need analyzing expertise, low sensitivity , need invasive test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sensitivity low to high

A

karyotyping, fish, pcr, nested pcr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

specificity

A

good for karyotyping, fish, pcr, not nested pcr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

FISH

A

denature dna, add hybridization probes (flor labled), expose to UV light to get signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what size dna for FISH

A

400-500 kb … span large areas of genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

FISH for diagnosis pros

A

quantitative, easy to interpret, sensitive to use PB, works for interphase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

FISH cons

A

expensive, time consuming, need enough cells to analyze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PCR diagnosis pros

A

sensitive economical, use BM or PB, rapid, doesn’t require dividing cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how sensitive is PCR

A

1/10k to 100k

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PCR diagnosis cons

A

need isolate RNA (unstable), may miss some rare breakpts (in exons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BCR ABL colors

A

bcr - red, abl - green, fusion - yellow

17
Q

how PCR works

A

design fwd/reverse primers. fusion gene gives product

18
Q

ABL breakpt region

A

intron bw exon 1, 2

19
Q

pcr starts w rna or dna

A

rna

20
Q

small # of pcr primer sets can amplify what

A

multiple versions of fusion gene

21
Q

pcr output is easy to read? must include what

A

easy to read output. must include internal PCR control to differentiate bw neg & failed result

22
Q

nested pcr test sensitivity for translocation

A

1 molecule in 10 000 k (rlly high, not great when detect transcrip at low levels which happen all the time)

23
Q

specific amplification of target dna involves

A

using product from 1st pcr round as input for 2nd. 1st set primers (outer). 2nd set primers (inner)

24
Q

qualitative essay

A

yes or no. for initial diagnosis.

25
Q

quantitative

A

info about amt of biomarker. need after treatment to track relative amt of bcr/abl

26
Q

QRT-PCR

A

polymerization , strand displacement, cleavage , polymerization complete

27
Q

qrt-pcr polymerization involves

A

fwd, reverse primer. probe w reporter, quencher. cleave reporter so it flors, show # copies pcr

28
Q

reporter shows up more

A

at later cycles & as you further dilute it

29
Q

decr in bcr-abl gene transcript (biomarker) levels show

A

decr in cytogenetic response, correlating to assay sensitivity

30
Q

cytogenetic vs molecular assays

A

molecular assays more sensitive, cytogenetic = less

31
Q

recurrence of disease after initial response assoc w

A

extra mutations in orig biomarker (not just fusion, but becomes resistant to imatinib)

32
Q

why use other drugs after treatment

A

to decr biomarkers again as tumour still evolving

33
Q

diagnostic test for CML

A

detect philadelphia xsome

34
Q

diagnostic testing evolves as

A

muchs of resistance becomes clear… 1 mutation but at diff breakpts so it still happens in diff ways